HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-nitrosomethyl(2-oxobutyl)amine

Also Known As:

M-2-OB; 2-Butanone, 1-((nitrosomethyl)amino)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Nitroso Compounds: 446
  - Nitrosamines: 1539
    - N-nitrosomethyl(2-oxobutyl)amine: 1

Related Diseases

1.	Cholangiocarcinoma 10/01/1983 - "M-2-OB predominantly affected the lip (epitheliomas, squamous cell carcinomas), liver (cholangiomas and cholangiocarcinomas), and flank organ (epitheliomas, squamous cell carcinomas). "
2.	Neoplasms (Cancer) 10/01/1983 - "In contrast to M-2-OB, M-3-OB did not induce renal and urethral tumors. " 10/01/1983 - "M-2-OB, although given in significantly smaller doses (minimum dose, 2.3 mg/kg body weight) than was M-3-OB (minimum dose, 17.6 mg/kg body weight), induced a much broader spectrum of neoplasms (in 17 tissues), whereas M-3-OB induced tumors in only 5 tissues and had no carcinogenic effect in the pancreas. "
3.	Bile Duct Adenoma 10/01/1983 - "M-2-OB predominantly affected the lip (epitheliomas, squamous cell carcinomas), liver (cholangiomas and cholangiocarcinomas), and flank organ (epitheliomas, squamous cell carcinomas). "
4.	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/01/1983 - "M-2-OB predominantly affected the lip (epitheliomas, squamous cell carcinomas), liver (cholangiomas and cholangiocarcinomas), and flank organ (epitheliomas, squamous cell carcinomas). "
5.	Carcinoma (Carcinomatosis) 10/01/1983 - "M-2-OB predominantly affected the lip (epitheliomas, squamous cell carcinomas), liver (cholangiomas and cholangiocarcinomas), and flank organ (epitheliomas, squamous cell carcinomas). "

Related Drugs and Biologics

1.	N-nitrosomethyl(3-oxobutyl)amine